Xtra-Gold Resources Corp. announced an updated Mineral Resource Estimate for its Kibi Gold Project in Ghana, revealing an Indicated Mineral Resource of approximately 1.4 million ounces of gold and an additional 180,800 ounces inferred. The update includes new drilling data from 123 diamond drill holes since 2024, covering eleven gold deposits within a 4.5 km area. This milestone validates the project's multi-million-ounce potential and supports ongoing exploration efforts to expand resources further. The company awaits formal approval for an extension of its mining lease covering a key buffer zone, which is critical for future development plans.
Xtra-Gold's updated Mineral Resource Estimate for the Kibi Gold Project provides context for readers interested in gold-related assets. On Pluang, 38 of 62 Basic Materials-sector US stocks rose while 20 fell as of Oct 13, 2026 19:12 WIB. Notable movers include IAG at USD 18.80 with a 1.24% increase, GGB at USD 5.20 up 1.17%, and CDE at USD 16.95 rising 1.13%.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
